[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-341933-105":59,"doc-detail-341933-en":131},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":124,"head_meta":126,"extra_data":128,"updated_unix":130},105,"en","erbb2-is-a-potential-diagnostic-and-prognostic-biomarker-in-renal-clear-cell-carcinoma","ERBB2 is a potential diagnostic and prognostic biomarker in renal clear cell carcinoma","","Renal clear cell carcinoma (ccRCC) remains a common kidney malignancy, and earlier, more effective biomarkers could improve long-term patient survival. This study evaluates ERBB2, an Erb-b2 receptor tyrosine kinase 2 involved in proliferation, differentiation, and apoptosis regulation, for diagnostic and prognostic relevance in ccRCC. Using TCGA and GEO expression datasets, survival and ROC analyses, immune infiltration and checkpoint associations, plus methylation and genetic alteration profiling, ERBB2 shows tumor-lower expression with clinicopathologic links and predictive value for overall and disease-specific outcomes.",{"@graph":69,"@context":123},[70,84,106],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/erbb2-is-a-potential-diagnostic-and-prognostic-biomarker-in-renal-clear-cell-carcinoma/341933/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/erbb2-is-a-potential-diagnostic-and-prognostic-biomarker-in-renal-clear-cell-carcinoma/341933.png","ImageObject",300,407,{"name":92,"@type":93},"River Wang","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-01","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":105},"InteractionCounter",{"@type":104},"ViewAction",15,{"@type":107,"mainEntity":108},"FAQPage",[109,115,119],{"name":110,"@type":111,"acceptedAnswer":112},"What was the purpose of the study on ERBB2 in ccRCC?","Question",{"text":113,"@type":114},"To investigate whether ERBB2 has diagnostic and prognostic roles in renal clear cell carcinoma and to assess its associations with clinical features and outcomes.","Answer",{"name":116,"@type":111,"acceptedAnswer":117},"How was ERBB2 expression evaluated across datasets?",{"text":118,"@type":114},"Expression levels were analyzed using TCGA and GEO, including differential expression testing between high and low ERBB2 groups in the TCGA-KIRC dataset.",{"name":120,"@type":111,"acceptedAnswer":121},"What evidence supports ERBB2 as a prognostic and diagnostic marker?",{"text":122,"@type":114},"ERBB2 expression correlated with immune infiltration, immune checkpoints, PTEN, and DNA methylation at ERBB2 CpG islands, while survival analyses and ROC curves indicated potential predictive and discriminative value between tumor and adjacent normal tissues.","https://schema.org",{"og:url":83,"og:type":125,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":127,"canonical":83},"index,follow",{"doc_id":129,"site_id":62},341933,1790456355,{"code":4,"msg":5,"data":132},{"doc_id":129,"user_id":133,"nickname":92,"user_avatar":134,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":140,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":141,"language":142,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":143,"faqs":144,"seo_title":145,"seo_description":67,"update_tm":146,"read_time":147,"preview_page_count":19,"preview_urls":148},1099514067438,"https://ap-avatar.wpscdn.com/avatar/100002539ee87300030?x-image-process=image/resize,m_fixed,w_180,h_180&k=1780474512215547542","[www. nature.com/scientificreports](www. nature.com/scientificreports)  \nOPEN  \nERBB2 is a potential diagnostic and prognostic biomarker in renal clear cell carcinoma  \nWu-niri Gao1,6, Li-gang Chen2,6, Lu-ri Bao3, Ning He4, Ta-la Hu1, Can Lai5, Rui-feng Xu1, Xi-feng Wang4, Jing-yuan Wang3, Jian-rong Zhao1 & Yan Meng1􀀍  \nRenal clear cell carcinoma (ccRCC) is a common parenchymal tumor of the kidney, and the discovery of biomarkers for early and effective diagnosis of ccRCC can improve the early diagnosis of patients and thus improve long-term survival. Erb-b2 receptor tyrosine kinase 2 (ERBB2) mediates the processes of cell proliferation, differentiation, and apoptosis inhibition. The purpose of this study was to investigate the diagnostic and prognostic role of ERBB2 in ccRCC. We analyzed the expression levels of ERBB2 in various cancers from The Cancer Genome Atlas (TCGA) and Gene Expression Omnibus (GEO) databases. RNA-seq data were analyzed using R packages to identify differentially expressed genes between the high and low ERBB2 expression groups in theTCGA-KIRC dataset. Spearman correlation analysis was performed to determine the correlation between ERBB2 expression and immune cell infiltration, immune checkpoint expression, and PTEN expression. DNA methylation changes and genetic alterations in ERBB2 were assessed using the MethSurv and cBioPortal databases. Logistic regression analysis was performed to determine the correlation between ERBB2 expression and the clinicopathological characteristics of ccRCC patients. The diagnostic and prognostic value of ERBB2 was assessed using Kaplan‒Meier (K‒M) survival curves, diagnostic ROC curves, time-dependent ROC curves, nomogram models, and Cox regression models. The expression level of ERBB2 is lower in tumor tissues of ccRCC patients than in the corresponding control tissues. Differentially expressed genes associated with ERBB2 were significantly enriched in the pathways“BMP2WNT4FOXO1 pathway in primary endometrial stromal cell differentiation” and “AMAN pathway”. In ccRCC tissues, ERBB2 expression levels were associated with immune cell infiltration, immune checkpoints, and PTEN. The DNA methylation status of 10 CpG islands inthe ERBB2 gene was associated with the prognosis ofccRCC. ERBB2 expression levels in ccRCC tissues were associated with race, sex, T stage, M stage, histological grade, and pathological stage. Cox regression analysis showed that ERBB2 was a potential independent predictor of overall survival (OS), disease-specific survival (DSS), and progression-free interval (PFI) in ccRCC patients. ROC curve analysis showed that the expression level of ERBB2 could accurately distinguish between ccRCC tissue and adjacent normal renal tissue. Our study showed that ERBB2 expression in ccRCC tissues can be of clinical importance as a potential diagnostic and prognostic biomarker.  \nKeywords ERBB2, Renal clear cell carcinoma, Clinical outcome, Immune cell infiltration, DNA methylation, Tumor prognosis  \nAbbreviations  \nccRCC Renal clear cell carcinoma  \nERBB2 Erb-b2 receptor tyrosine kinase 2 TCGA The cancer genome atlas  \nGEO Gene expression omnibus  \n1Department of Nephrology, The Affiliated Hospital of Inner Mongolia Medical University, Hohhot 010050, Inner Mongolia, People’s Republic of China. 2Department of Urology, The Affiliated Hospital of Inner Mongolia Medical University, Hohhot, People’s Republic of China. 3Department of Pathology, School of Basic Medicine, Inner Mongolia Medical University, Hohhot, People’s Republic of China. 4Hemodialysis Room, The No. 2 Hospital of Hohhot, Hohhot, People’s Republic of China. 5Department of Gastrointestinal Surgery, Inner Mongolia Campus of Peking University Cancer Hospital (The Affiliated Cancer Hospital of Inner Mongolia Medical University), Hohhot, People’s Republic of China. 6Wu-niri Gao and Li-gang Chen have contributed equally to this work. 􀀍 email: [mbao124@qq.com](mbao124@qq.com)  \n[www. nature.com/scientificreports/](w","cbCaibghpSDmqq5x","https://ap.wps.com/l/cbCaibghpSDmqq5x","pdf",6413213,16,18,"English","# ERBB2 in renal clear cell carcinoma\n## Study aim and rationale\n## Bioinformatic analyses and data sources\n## ERBB2 expression differences\n## Immune microenvironment and checkpoints\n## DNA methylation and genetic alterations\n## Clinicopathological associations\n## Diagnostic and prognostic modeling","[{\"question\":\"What was the purpose of the study on ERBB2 in ccRCC?\",\"answer\":\"To investigate whether ERBB2 has diagnostic and prognostic roles in renal clear cell carcinoma and to assess its associations with clinical features and outcomes.\"},{\"question\":\"How was ERBB2 expression evaluated across datasets?\",\"answer\":\"Expression levels were analyzed using TCGA and GEO, including differential expression testing between high and low ERBB2 groups in the TCGA-KIRC dataset.\"},{\"question\":\"What evidence supports ERBB2 as a prognostic and diagnostic marker?\",\"answer\":\"ERBB2 expression correlated with immune infiltration, immune checkpoints, PTEN, and DNA methylation at ERBB2 CpG islands, while survival analyses and ROC curves indicated potential predictive and discriminative value between tumor and adjacent normal tissues.\"}]","ERBB2 is a potential diagnostic and prognostic biomarker in renal clear cell carcinoma | PDF",1790044390,45,[149,153,157,161],{"page_no":8,"url":150,"width":151,"height":152},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/41b104ae6cef6e1e693984a42e7abb1c.webp",983,1291,{"page_no":14,"url":154,"width":155,"height":156},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/7fcf4466ae2d20f218c0cac2b21035b6.webp",982,1290,{"page_no":81,"url":158,"width":159,"height":160},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/281e673ca58bd43f9bcba438dffe96db.webp",981,1289,{"page_no":19,"url":162,"width":163,"height":164},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/a41ed0e72cd6424e17f70d8ecc34eed3.webp",980,1287]